Skip to main content
Head & Face Medicine logoLink to Head & Face Medicine
. 2023 Jun 29;19:25. doi: 10.1186/s13005-023-00371-4

The applied value in brain gray matter nuclei of patients with early-stage Parkinson’s disease : a study based on multiple magnetic resonance imaging techniques

Heng Meng 1, Duo Zhang 1,, Qiyuan Sun 1
PMCID: PMC10308637  PMID: 37386479

Abstract

Purpose

This study compares the observation efficiency of brain gray matter nuclei of patients with early-stage Parkinson’s disease among various Magnetic Resonance Imaging techniques, which include susceptibility weighted imaging (SWI), quantitative susceptibility imaging (QSM), diffusion tensor imaging (DTI) and diffusion kurtosis imaging (DKI). Based on the findings, this study suggests an efficient combination of scanning techniques for brain gray matter nuclei observation, aiming to provide an opportunity to advance the understanding of clinical diagnosis of early-stage Parkinson’s disease.

Methods

Forty examinees, including twenty patients who were clinically diagnosed with early Parkinson’s disease with a course of 0.5-6 years (PD group) and twenty healthy controls (HC group), underwent head MRI examination. Philips 3.0T (tesla) MR machine was used to measure the imaging indexes of gray matter nuclei in patients with early Parkinson’s disease. SWI, QSM, DTI and DKI were used for diagnosis. SPSS (Statistical Product and Service Solutions) 21.0 was used for data analysis.

Results

When SWI was used, fifteen PD patients and six healthy volunteers were diagnosed correctly. The sensitivity, specificity, positive predictive value, negative predictive value and diagnostic coincidence rate about the diagnosis of nigrosome-1 on imaging were 75.0%, 30.0%, 51.7%, 54.5% and 52.5% respectively. By contrast, when QSM was used, 19 PD patients and 11 healthy volunteers were diagnosed correctly. The sensitivity, specificity, positive predictive value, negative predictive value and diagnostic coincidence rate about the diagnosis of Nigrosome-one on imaging were 95.0%, 55.0%, 67.9%, 91.7% and 75.0% respectively. The mean kurtosis (MK) value within both the substantia nigra and thalamus, together with the mean diffusivity (MD) within both the substantia nigra and the head of caudate nucleus in PD group was greater than that of HC group. The susceptibility values within the substantia nigra, red nucleus, head of caudate nucleus and putamen of PD group was greater than that of HC group. The MD value in substantia nigra reveals the optimal diagnostic efficiency to distinguish the HC group and the PD group, followed by the MK value in substantia nigra. Specifically, the maximum area under ROC curve (AUC) of the MD value was 0.823, the sensitivity 70.0%, the specificity 85.0%, and the diagnostic threshold 0.414. The area under ROC curve (AUC) of the MK value was 0.695, the sensitivity 95.0%, the specificity 50.0%, and the diagnostic threshold was 0.667. Both of them were statistically significant.

Conclusions

In the early diagnosis of Parkinson’s disease, QSM is more efficient than SWI in observing nigrosome-1 in substantia nigra. In the early diagnosis of Parkinson’s disease, MD and MK values of substantia nigra in DKI parameters have higher diagnostic efficiency. The combined scanning of DKI and QSM has the highest diagnostic efficiency and provides imaging basis for clinical diagnosis of early Parkinson’s disease.

Keywords: Parkinson’s disease, Magnetic resonance imaging, Diffusion tensor imaging, Diffusion kurtosis imaging, Quantitative susceptibility mapping, Susceptibility weighted imaging

Background

Parkinson’s disease (PD), also known as paresis agitans, is a common extrapyramidal disease in the elderly. It is only second to Alzheimer’s disease in terms of incidence among all the brain degenerative diseases. At present, the etiology and pathogenesis of Parkinson’s disease are not clear. Modern medical research suggests that the etiology of Parkinson’s disease may include age and heredity, and the pathogenesis includes oxidative stress injury, excitatory neurotoxicity, homocysteine, immune inflammatory reaction, mitochondrial dysfunction, apoptosis and autophagy [1]. Disorder of iron metabolism and abnormal deposition in brain may lead to neurodegenerative diseases such as Parkinson’s disease. Studies have shown that the iron content in substantia nigra of patients with Parkinson’s disease increased significantly [2], and with the aggravation of the disease, the iron deposition increased [3]. Although the biological mechanism of abnormal iron metabolism in patients with Parkinson’s disease is not clear, it is certain that the disease is closely related to the imbalance of iron absorption, storage and release in vivo, which is likely to be the main factor leading to the loss of dopamine neurons and abnormal aggregation of α-synuclein [4].

In the conventional plain scan sequence, the substantia nigra of normal people showed high signal on T1 weighted imaging (T1WI) and proton density weighted imaging (PDWI), but low signal on T2 weighted imaging (T2WI) and diffusion tensor imaging (DTI) [5]. In patients with Parkinson’s disease, the outline and volume of substantia nigra were abnormal, and the dense part of substantia nigra atrophied and narrowed. Some studies have found that on T1WI, the substantia nigra signal of PD patients can be reduced with the progress of disease [6]. T2*WI、SWI and other techniques are more precise and accurate in displaying the anatomical structure of substantia nigra [7]. Some studies have shown that high signal circular area can be seen in substantia nigra on T2*WI, which is confirmed to be corresponding to substantia nigra-1, which is the most vulnerable site of Parkinson’s disease [8]. Because diffusion tensor imaging (DTI) is the only noninvasive examination method to observe and track the white matter fiber tracts based on the water molecule moving direction, it can show the changes of microstructure before the macroscopic changes. Some researchers found that the FA (fractional anisotropy) values of substantia nigra, striatum, putamen and other nuclei in Parkinson’s disease patients were significantly decreased, suggesting nuclear degeneration [9]. However, some studies found that FA value and MD (mean diffusivity) value of PD patients had no significant change compared with those of normal control group [10]. Schwarz et al. conducted a meta-analysis on the previous literature and found that FA and MD values were not credible as diagnostic indicators [11]. Therefore, the reliability of DTI in the diagnosis of PD needs further study and analysis. DKI is an extension of diffusion tensor imaging (DTI). In the study of Parkinson’s disease with DKI technique, it was found that the MK values of substantia nigra, caudate nucleus, putamen and globus pallidus of PD patients were significantly higher than those of normal people, and FA values of substantia nigra were significantly higher than those of normal people. FA values of other gray matter nuclei were not statistically different from those of normal people. The common parameters of DTI included MD (mean diffusivity), AD (axial diffusivity), RD (radial diffusivity) and ADC (average diffusion coefficient). There was no significant difference between Parkinson’s disease patients and normal control group [12].

Therefore, the study compared the DKI-MK (mean kurtosis) value, DKI-AK (axial kurtosis) value, DKI-RK (radial kurtosis) value, DKI-RD (radial diffusivity) value, DKI-FA (fractional anisotropy) value, DTI-FA value, DTI-ADC value, magnetic susceptibility value of deep gray matter nuclei in PD group and HC group, and observed and determined the swallow tail sign of bilateral substantia nigra in SWI and QSM images, so as to provide objective basis for MRI diagnosis of Parkinson’s disease.

Research object

The study was approved by the ethics committee of Affiliated Hospital of Beihua University. All examinees signed informed consent. Forty examinees underwent head MRI examination. Twenty patients (PD group) were clinically diagnosed with early Parkinson’s disease, 8 males and 12 females, with an average age of 66.50 ± 9.65 years and a course of 0.5-6 years. The average score of the UPDRS - III (Unified Parkinson’s Disease Rating Scale-III) was (18.4 ± 9.4). The other twenty examinees were healthy controls (HC group), 13 males and 7 females, with an average age of 61.25 ± 6.87 years.

According to the latest diagnostic criteria of PD published by the movement disorder Society (MDS) in 2015, the patients with secondary Parkinson’s syndrome were excluded; the Hoehn Yahr grading scale of PD was 1-1.5; the history of craniocerebral inflammation, swelling, trauma, operation history was excluded; the patients with mental illness and unable to cooperate with the examination were excluded.

Methods

All patients underwent SWI, DTI, DKI and QSM sequence scanning on 3.0T MRI machine (Ingenia; Philips, best, the Netherlands), and the scan sequence parameters (Table 1).

Table 1.

MRI scanning parameters

Name TR
(ms)
TE
(ms)
Thickness (mm) Number FOV
(mm×mm)
b
(sec/mm2)
SWI 31 7.2/delta 6.2 2 130 230 × 189
DTI 2773 85 2.5 48 224 × 224 0, 800
DKI 3b 3339 101 4 18 220 × 220 0, 1000, 2000
DKI 5b 3473 101 4 18 220 × 220 0, 500, 1000, 1500, 2000
QSM 57 8/delta 6.3 2 18 220 × 220

Note: SWI (susceptibility weighted imaging), DTI (diffusion tensor imaging), DKI (diffusion kurtosis imaging), QSM (quantitative susceptibility mapping), TR (time of repetition), TE (time of echo), FOV (field of view), b (diffusion sensitive factor)

The original image of DKI was exported in DICOM format. The images were preprocessed and classified. After post-processing with DKE (diffusion kurtosis estimator) software, mean kurtosis (MK), axial kurtosis (AK), radial kurtosis (RK), mean dispersion (MD) and fractional anisotropy (FA) were obtained. The parameters were imported into SPIN LITE software, which were read by two MRI doctors. The region of interest (ROI) was generated by hand animation, and the parameters MK, AK, RK, MD and FA were measured respectively.

After importing the scanned DTI images into Philips post-processing workstation, FA, ADC and neurotractography were obtained. The area of interest (ROI) was generated by hand animation and the parameters FA and ADC were measured.

The original image of QSM was exported in DICOM format, the data were preprocessed and classified, and the susceptibility parameter map was obtained by post-processing with Matlab software. The parameters were imported into image J software, which were read by two MRI doctors. The region of interest (ROI) was generated by hand animation and the parameter magnetic susceptibility was measured. Then the bilateral nigrosome-1 was observed.

The original SWI images were divided into amplitude map, phase map and angiogram. The images were read by two MRI doctors. The bilateral nigrosome-1 was observed by amplitude map.

The structure of bilateral igrosome-1 was judged on QSM image and SWI amplitude map. Based on the naked eye observation, it can be divided into three situations: clearly visible, suspected visible and invisible. According to the imaging diagnosis, the examinees were divided into three groups: ①Normal group: bilateral igrosome-1 was clearly visible; ② PD group: at least one side of igrosome-1 was not visible, including bilateral invisible, one side visible or suspected visible, the other side was not visible; ③Uncertain diagnosis group: the visibility of igrosome-1 was in other conditions, including bilateral igrosome-1 suspected visible, one side clearly visible, the other side suspected visible.

The DKI-MK value, DKI-AK value, DKI-RK value, DKI-RD value, DKI-FA value, DTI-FA value, DTI-ADC value and magnetic susceptibility value of five regions of interest (ROI) of bilateral substantia nigra, red nucleus, head of caudate nucleus, putamen and thalamus were selected. The igrosome-1 of bilateral substantia nigra in SWI and QSM images were observed and determined.

Data analysis

SPSS 21.0 statistical software was used for analysis, and the observation value of each image was expressed as (Inline graphic). The process of data analysis is as follows:

(1) Age (t test) and gender (χ2test) were compared between PD group and HC group.

(2) The presence/absence of Nigerome-1 was observed by SWI and QSM respectively and was later used as imaging diagnosis of Parkinson’s disease. The imaging diagnosis was then compared with the clinical diagnosis, the gold standard in the study, in the following aspects: sensitivity, specificity, positive predictive value, negative predictive value and diagnostic coincidence rate.

(3) The t test (normal distribution) and nonparametric test (non normal distribution) were used to compare.

  1. the parameters (DKI, DTI, QSM) of each nucleus between the PD group and the HC group;

  2. the parameters of each nucleus between DKI3b and DKI5b images within the HC group;

  3. the parameters of each nucleus (DKI, DTI, QSM) between the PD group and the HC group.

(4) Pearson (bivariate normal distribution) / Spearman (bivariate incomplete normal distribution) correlation analysis was used to compare the correlation between the parameters of nuclei in PD group (DKI3b) and PD group (QSM). The correlation is considered statistically significant when p value is lower than 0.05.

Results

Clinical data of 40 examinees

There was no significant difference in age and gender between the two groups (p > 0.05) (Table 2).

Table 2.

Clinical data of PD group and HC group

Variables PD group HC group p
Number 20 20 -
Age 66.50 ± 9.65 61.25 ± 6.87 0.055*
Gender (male / female) 8/12 13/7 0.113**

Note: *Age comparison between PD group and HC group, **Gender comparison between PD group and HC group

Visibility and diagnostic efficiency of SWI and QSM on Nigrosome-1 in substantia nigra

Based on SWI, 15 PD patients and 6 healthy volunteers were correctly diagnosed. The sensitivity, specificity, positive predictive value, negative predictive value and diagnostic coincidence rate of Nigrosome-1 for PD were 75.0%, 30.0%, 51.7%, 54.5%, and 52.5%, respectively. The positive likelihood ratio (+ LR) was 1.07, negative likelihood ratio (-LR) was 0.83 (Table 3).

Table 3.

The relationship between the prevalence of PD group and HC group and the results of SWI

SWI Gold Standard Total
PD group HC group
PD group 15 14 29
HC group 5 6 11
Total 20 20 40

According to QSM, 19 PD patients and 11 healthy volunteers were diagnosed correctly. The sensitivity, specificity, positive predictive value and negative predictive value of one in the diagnosis of PD were 95.0%, 55.0%, 67.9%, 91.7% and 75.0%, respectively. The positive likelihood ratio (+ LR) was 2.11, negative likelihood ratio(-LR) was 0.09 (Table 4) (Fig. 1).

Table 4.

The relationship between the prevalence of PD and HC and the results of QSM

QSM Gold Standard Total
PD group HC group
PD group 19 9 28
HC group 1 11 12
Total 20 20 40

Fig. 1.

Fig. 1

On the substantia nigra of SWI images

①HC group, female, 58 years old (bilateral Nigrosome-1 showed clearly)

②PD group, female, 63 years old, course of disease 1 year (right Nigrosome-1 is not clear, left Nigrosome-1 is clear)

③PD group, female, 65 years old, course of disease 5 years (bilateral Nigrosome-1 is not clear)

Comparison of DKI5b parameters between left and right sides of ROI position in HC group

There was no significant difference between the left and right sides of ROI position in healthy subjects (p > 0.05) (Table 5).

Table 5.

The parameters of DKI5b in HC group were compared in ROI position

ROI position parameter L(Inline graphic) R(Inline graphic) t/Z p
Substantia nigra MK 0.79 ± 0.23 0.84 ± 0.24 -0.615 0.542
AK 0.59 ± 0.23 0.68 ± 0.24 -1.244z 0.213
RK 0.89 ± 0.23 0.87 ± 0.30 -0.352z 0.725
MD 0.37 ± 0.06 0.36 ± 0.06 0.746 0.460
FA 0.21 ± 0.07 0.20 ± 0.04 -0.108z 0.914
Red nucleus MK 0.76 ± 0.29 0.76 ± 0.32 -0.076 0.940
AK 0.49 ± 0.24 0.57 ± 0.26 -0.622z 0.534
RK 0.87 ± 0.33 0.90 ± 0.38 -0.317 0.753
MD 0.39 ± 0.07 0.38 ± 0.06 0.466 0.644
FA 0.19 ± 0.04 0.19 ± 0.04 -0.287z 0.774
Head of caudate nucleus MK 0.60 ± 0.40 0.55 ± 0.38 0.448 0.659
AK 0.54 ± 0.33 0.67 ± 0.40 -1.079 0.287
RK 0.77 ± 0.45 0.74 ± 0.46 0.238 0.815
MD 0.41 ± 0.07 0.44 ± 0.09 -1.447 0.156
FA 0.09 ± 0.03 0.08 ± 0.02 1.476 0.148
Putamen MK 0.45 ± 0.20 0.53 ± 0.14 -1.354 0.184
AK 0.55 ± 0.21 0.62 ± 0.24 -1.082z 0.279
RK 0.55 ± 0.20 0.66 ± 0.27 -1.465 0.151
MD 0.41 ± 0.08 0.43 ± 0.13 -0.108z 0.914
FA 0.10 ± 0.04 0.08 ± 0.02 -1.136z 0.256
Thalamus MK 0.61 ± 0.28 0.60 ± 0.26 0.156 0.877
AK 0.55 ± 0.17 0.52 ± 0.16 0.673 0.505
RK 0.74 ± 0.27 0.73 ± 0.25 0.025 0.980
MD 0.42 ± 0.08 0.43 ± 0.08 -0.408 0.685
FA 0.14 ± 0.03 0.13 ± 0.02 1.413 0.166

Note: z-rank sum test

Comparison of DKI3b parameters between left and right sides of ROI position in HC group

There was no significant difference between the left and right sides of ROI position in HC group (p > 0.05) (Table 6).

Table 6.

The parameters of DKI3b in HC group were compared in ROI position

ROI position Parameter L(Inline graphic) R(Inline graphic) t/Z p
Substantia nigra MK 0.74 ± 0.34 0.76 ± 0.30 -0.245 0.808
AK 0.53 ± 0.25 0.59 ± 0.32 -0.271z 0.787
RK 0.75 ± 0.36 0.93 ± 0.35 -1.598 0.118
MD 0.37 ± 0.05 0.36 ± 0.05 0.607 0.548
FA 0.21 ± 0.07 0.20 ± 0.04 0.327 0.746
Red nucleus MK 0.67 ± 0.41 0.78 ± 0.36 -0.839z 0.402
AK 0.54 ± 0.29 0.73 ± 0.40 -1.717 0.094
RK 0.80 ± 0.34 0.78 ± 0.36 -0.108z 0.914
MD 0.40 ± 0.07 0.40 ± 0.08 0.158 0.875
FA 0.19 ± 0.05 0.19 ± 0.04 0.352 0.726
Head of caudate nucleus MK 0.60 ± 0.39 0.58 ± 0.39 0.186 0.854
AK 0.61 ± 0.35 0.55 ± 0.34 0.513 0.611
RK 0.78 ± 0.45 0.74 ± 0.46 0.223 0.824
MD 0.41 ± 0.08 0.43 ± 0.10 -0.567 0.574
FA 0.10 ± 0.03 0.09 ± 0.03 -0.568z 0.570
Putamen MK 0.63 ± 0.30 0.55 ± 0.26 0.956 0.345
AK 0.59 ± 0.19 0.63 ± 0.22 -0.501 0.619
RK 0.66 ± 0.27 0.65 ± 0.26 0.105 0.917
MD 0.40 ± 0.10 0.42 ± 0.14 -0.974 0.330
FA 0.09 ± 0.03 0.08 ± 0.03 1.126 0.267
Thalamus MK 0.67 ± 0.23 0.64 ± 0.22 0.373 0.711
AK 0.51 ± 0.21 0.62 ± 0.25 -1.409 0.167
RK 0.71 ± 0.18 0.64 ± 0.20 1.112 0.273
MD 0.41 ± 0.08 0.42 ± 0.07 -0.356 0.723
FA 0.15 ± 0.04 0.13 ± 0.03 1.322 0.194

Note: z-rank sum test

Comparison of DKI parameters with different b values between left and right sides of ROI positions in HC group

There was no significant difference in ROI position between DKI3b and DKI5bin HC group. (p > 0.05) (Table 7).

Table 7.

Comparison of DKI3b and DKI5b parameters of ROI positions in HC group

ROI position Parameter DKI3b(Inline graphic) DKI5b(Inline graphic) t/Z p
Substantia nigra MK 0.75 ± 0.23 0.82 ± 0.17 -1.093 0.288
AK 0.56 ± 0.21 0.64 ± 0.21 -1.008z 0.313
RK 0.84 ± 0.24 0.88 ± 0.22 -0.606 0.552
MD 0.37 ± 0.05 0.36 ± 0.06 0.446 0.661
FA 0.20 ± 0.05 0.20 ± 0.05 0.042 0.967
Red nucleus MK 0.72 ± 0.31 0.76 ± 0.22 -0.386 0.704
AK 0.63 ± 0.22 0.53 ± 0.19 -1.120z 0.263
RK 0.79 ± 0.27 0.88 ± 0.22 -1.139 0.269
MD 0.40 ± 0.07 0.39 ± 0.07 1.086 0.291
FA 0.19 ± 0.04 0.19 ± 0.04 -0.402 0.692
Head of caudate nucleus MK 0.58 ± 0.30 0.58 ± 0.31 -0.822z 0.411
AK 0.58 ± 0.25 0.61 ± 0.27 -0.331 0.745
RK 0.76 ± 0.35 0.76 ± 0.34 -1.926z 0.054
MD 0.42 ± 0.08 0.42 ± 0.07 -0.400 0.694
FA 0.09 ± 0.02 0.09 ± 0.02 1.565 0.134
Putamen MK 0.59 ± 0.22 0.49 ± 0.13 1.745 0.099
AK 0.61 ± 0.16 0.59 ± 0.19 0.557 0.584
RK 0.65 ± 0.22 0.60 ± 0.18 0.825 0.419
MD 0.41 ± 0.11 0.42 ± 0.10 − .299z 0.765
FA 0.09 ± 0.03 0.09 ± 0.03 -0.055 0.957
Thalamus MK 0.66 ± 0.20 0.60 ± 0.21 0.839 0.412
AK 0.56 ± 0.20 0.53 ± 0.13 0.562 0.581
RK 0.67 ± 0.12 0.74 ± 0.21 -1.145 0.266
MD 0.42 ± 0.07 0.43 ± 0.08 -0.433 0.670
FA 0.14 ± 0.03 0.14 ± 0.03 0.175 0.863

Note: z-rank sum test

Comparison of DKI3b parameters between left and right sides of ROI in PD group

There was no significant difference between the left and right sides of ROI in PD group (p > 0.05) (Table 8) (Fig. 2).

Table 8.

Comparison of DKI3b parameters between left and right sides of ROI positions in PD group

ROI position Parameter L(Inline graphic) R(Inline graphic) t/Z p
Substantia nigra MK 0.96 ± 0.30 0.93 ± 0.25 0.926 0.366
AK 0.60 ± 0.20 0.52 ± 0.17 -1.150z 0.250
RK 1.04 ± 0.49 0.90 ± 0.43 0.955 0.346
MD 0.46 ± 0.08 0.44 ± 0.06 -0.622z 0.534
FA 0.22 ± 0.08 0.21 ± 0.06 -0.325 0.745
Red nucleus MK 0.68 ± 0.31 0.74 ± 0.30 -0.613 0.543
AK 0.58 ± 0.26 0.52 ± 0.23 -1.393 0.164
RK 0.90 ± 0.42 0.89 ± 0.41 0.064 0.949
MD 0.44 ± 0.07 0.45 ± 0.08 -0.392 0.695
FA 0.20 ± 0.08 0.19 ± 0.06 -0.176z 0.860
Head of caudate nucleus MK 0.42 ± 0.28 0.47 ± 0.33 -0.298z 0.766
AK 0.57 ± 0.35 0.52 ± 0.39 -0.649z 0.516
RK 0.52 ± 0.32 0.59 ± 0.44 -0.566 0.575
MD 0.46 ± 0.09 0.50 ± 0.12 -0.974z 0.330
FA 0.10 ± 0.04 0.08 ± 0.02 -1.272z 0.204
Putamen MK 0.58 ± 0.21 0.48 ± 0.27 1.238 0.223
AK 0.56 ± 0.36 0.62 ± 0.34 -0.487z 0.626
RK 0.70 ± 0.27 0.55 ± 0.31 1.674 0.102
MD 0.46 ± 0.11 0.44 ± 0.10 -0.730 0.465
FA 0.10 ± 0.04 0.10 ± 0.04 -0.298z 0.766
Thalamus MK 0.52 ± 0.26 0.55 ± 0.31 -0.325z 0.745
AK 0.54 ± 0.25 0.56 ± 0.29 -0.054z 0.957
RK 0.74 ± 0.33 0.81 ± 0.36 -0.575 0.569
MD 0.45 ± 0.10 0.45 ± 0.10 -0.230z 0.818
FA 0.16 ± 0.07 0.15 ± 0.08 -0.717 0.473

Note: z-rank sum test

Fig. 2.

Fig. 2

A 68 year old man with Parkinson’s disease

A:B0 image of DKI original image (Substantia nigra, Red nucleus)

B:DKI-MK pseudo color image (Substantia nigra 0.95, Red nucleus 0.88)

C:DKI-AK pseudo color image(Substantia nigra 0.58, Red nucleus 0.46)

d:DKI-RK pseudo color image(Substantia nigra 1.32, Red nucleus1.07)

E:DKI-MD pseudo color image(Substantia nigra 0.52, Red nucleus 0.48)

F:DKI-FA pseudo color image(Substantia nigra 0.23, Red nucleus 0.22)

G:QSM image(Substantia nigra 0.20, red nucleus 0.19)

h:QSM image(Head of caudate nucleus 0.06, Putamen 0.04, Thalamus 0.01)

Comparison of ROI positions in DKI3bbetween PD group and HC group

Compared with that of HC group, The MK and MD in substantia nigra of PD group was significantly greater (p < 0.05) (Figs. 3 and 4). The MD of caudate nucleus head of PD group was significantly greater (p < 0.05) (Fig. 5). The MK of thalamus of PD group was significantly lower than that of the HC group (p < 0.05) (Fig. 6) (Table 9).

Fig. 3.

Fig. 3

Two groups of MK box-plot of substantia nigra (p = 0.020)

Fig. 4.

Fig. 4

Two groups of MD box-plot of substantia nigra (p < 0.001)

Fig. 5.

Fig. 5

Two groups of MD box-plot of head of caudate nucleus (p = 0.043)

Fig. 6.

Fig. 6

Two groups of MK box-plot of thalamus (p = 0.037)

Table 9.

Comparison of ROI positions in DKI3b between PD group and HC group

ROI position Parameter PD group (Inline graphic) HC group (Inline graphic) t/Z p
Substantia nigra MK 0.94 ± 0.27 0.75 ± 0.23 2.424 0.020
AK 0.56 ± 0.16 0.56 ± 0.21 -0.460z 0.646
RK 0.97 ± 0.39 0.84 ± 0.24 1.299 0.202
MD 0.45 ± 0.07 0.37 ± 0.05 4.055 < 0.001
FA 0.22 ± 0.06 0.2 ± 0.05 -0.189 0.850
Red nucleus MK 0.71 ± 0.23 0.72 ± 0.31 -0.207 0.837
AK 0.55 ± 0.20 0.63 ± 0.22 -1.407z 0.160
RK 0.90 ± 0.32 0.79 ± 0.27 1.162 0.252
MD 0.45 ± 0.07 0.40 ± 0.07 -1.758 0.079
FA 0.19 ± 0.06 0.19 ± 0.04 -0.216 0.829
Head of caudate nucleus MK 0.44 ± 0.27 0.59 ± 0.30 -1.704z 0.088
AK 0.54 ± 0.32 0.58 ± 0.25 -1.082z 0.279
RK 0.55 ± 0.32 0.76 ± 0.35 -1.839z 0.066
MD 0.48 ± 0.10 0.42 ± 0.08 2.097 0.043
FA 0.09 ± 0.03 0.09 ± 0.02 -1.109z 0.267
Putamen MK 0.53 ± 0.17 0.59 ± 0.21 -1.066 0.293
AK 0.59 ± 0.32 0.61 ± 0.16 -1.028z 0.304
RK 0.62 ± 0.18 0.65 ± 0.22 -0.491 0.626
MD 0.45 ± 0.10 0.41 ± 0.11 -1.488z 0.137
FA 0.10 ± 0.04 0.09 ± 0.03 -0.893z 0.372
Thalamus MK 0.54 ± 0.24 0.66 ± 0.20 -2.083 0.037
AK 0.55 ± 0.25 0.56 ± 0.20 -0.239 0.812
RK 0.78 ± 0.28 0.67 ± 0.12 1.483 0.146
MD 0.45 ± 0.10 0.42 ± 0.07 -0.839z 0.402
FA 0.15 ± 0.07 0.14 ± 0.03 -0.054z 0.957

Note: z-rank sum test

Comparison of DTI parameters between left and right sides of ROI in HC group

There was no significant difference in DTI parameters between left and right sides of ROI in HC group. (p > 0.05) (Table 10).

Table 10.

Comparison of DTI parameters between left and right sides of ROI positions in HC group

ROI position Parameter L(Inline graphic) R(Inline graphic) t/Z p
Substantia nigra FA 0.40 ± 0.12 0.42 ± 0.08 0.992 0.334
ADC 0.50 ± 0.10 0.49 ± 0.09 0.084 0.934
Red nucleus FA 0.48 ± 0.10 0.49 ± 0.11 0.380 0.708
ADC 0.47 ± 0.09 0.46 ± 0.09 0.523z 0.601
Head of caudate nucleus FA 0.19 ± 0.04 0.18 ± 0.03 0.475 0.640
ADC 0.66 ± 0.07 0.67 ± 0.05 0.499z 0.618
Putamen FA 0.18 ± 0.05 0.16 ± 0.06 1.858z 0.063
ADC 0.62 ± 0.04 0.65 ± 0.08 1.220z 0.222
Thalamus FA 0.26 ± 0.03 0.26 ± 0.03 0.322 0.751
ADC 0.67 ± 0.04 0.67 ± 0.04 1.532 0.142

Note: z-rank sum test

Comparison of DTI parameters between left and right sides of ROI in PD group

There was no significant difference in DTI parameters between left and right sides of ROI in PD group (p > 0.05) (Table 11) (Fig. 7).

Table 11.

Comparison of DTI parameters between left and right sides of ROI positions in PD group

ROI position Parameter L(Inline graphic) R(Inline graphic) t/Z p
Substantia nigra FA 0.39 ± 0.14 0.43 ± 0.07 1.831z 0.067
ADC 0.53 ± 0.11 0.54 ± 0.08 0.369 0.716
Red nucleus FA 0.46 ± 0.08 0.45 ± 0.07 0.146 0.885
ADC 0.49 ± 0.05 0.49 ± 0.06 0.370z 0.711
Head of caudate nucleus FA 0.20 ± 0.05 0.20 ± 0.04 0.234 0.818
ADC 0.67 ± 0.06 0.68 ± 0.08 0.969z 0.333
Putamen FA 0.17 ± 0.03 0.18 ± 0.04 0.647z 0.518
ADC 0.64 ± 0.09 0.64 ± 0.08 0.409z 0.682
Thalamus FA 0.28 ± 0.06 0.26 ± 0.04 1.916 0.071
ADC 0.68 ± 0.06 0.70 ± 0.05 2.046 0.055

Note: z-rank sum test

Fig. 7.

Fig. 7

A 68 year old man with Parkinson’s disease

①②⑤The pseudo color images of SWI, B0 and DTI-FA in substantia nigra and red nucleus

③④⑥The pseudo color images of SWI, B0 and DTI-FA in head of caudate nucleus, putamen and thalamus

Comparison of ROI positions in DTI parameters between PD group and HC group

There was no significant difference in DTI parameters between ROI positions of PD group and HC group (p > 0.05) (Table 12).

Table 12.

Comparison of ROI positions in DTI parameters between PD group and HC group

ROI position Parameter HC group (Inline graphic) PD group (Inline graphic) t/Z p
Substantia nigra FA 0.41 ± 0.09 0.41 ± 0.07 0.019 0.985
ADC 0.50 ± 0.09 0.53 ± 0.08 1.421z 0.155
Red nucleus FA 0.49 ± 0.09 0.45 ± 0.07 1.287 0.206
ADC 0.47 ± 0.08 0.49 ± 0.05 0.488z 0.626
Head of caudate nucleus FA 0.18 ± 0.02 0.20 ± 0.03 1.952 0.060
ADC 0.66 ± 0.05 0.67 ± 0.06 0.651z 0.515
Putamen FA 0.17 ± 0.05 0.18 ± 0.03 0.291 0.773
ADC 0.64 ± 0.05 0.64 ± 0.08 0.434z 0.665
Thalamus FA 0.26 ± 0.03 0.27 ± 0.05 0.527 0.602
ADC 0.67 ± 0.04 0.69 ± 0.05 1.470 0.150

Note: z-rank sum test

Comparison of QSM parameters between left and right sides of ROI positions in HC group

There was no significant difference in QSM parameters between the left and right sides of ROI positions in HC group (p > 0.05) (Table 13).

Table 13.

Comparison of QSM parameters between left and right sides of ROI positions in HC group

ROI position L(Inline graphic) R(Inline graphic) t/Z p
Substantia nigra 0.11 ± 0.08 0.13 ± 0.08 -1.759z 0.079
Red nucleus 0.10 ± 0.09 0.11 ± 0.08 -0.257z 0.797
Head of caudate nucleus 0.01 ± 0.04 0.02 ± 0.05 -0.835 0.409
Putamen 0.03 ± 0.04 0.02 ± 0.06 0.287 0.776
Thalamus 0.01 ± 0.03 -0.01 ± 0.04 1.701 0.097

Note: z-rank sum test

Comparison of QSM parameters between left and right sides of ROI positions in PD group

There was no significant difference in QSM parameters between the left and right sides of ROI positions in PD group (p > 0.05) (Table 14)(Fig. 2).

Table 14.

Comparison of QSM parameters between left and right sides of ROI positions in PD group

ROI position L(Inline graphic) R(Inline graphic) t/Z p
Substantia nigra 0.19 ± 0.06 0.19 ± 0.05 -0.129 0.899
Red nucleus 0.18 ± 0.06 0.18 ± 0.08 0.104 0.918
Head of caudate nucleus 0.07 ± 0.02 0.05 ± 0.02 1.905 0.073
Putamen 0.05 ± 0.02 0.06 ± 0.02 -0.391 0.700
Thalamus 0.00 ± 0.03 0.01 ± 0.02 -0.530z 0.596

Note: z-rank sum test

Comparison of ROI positions in QSM parameters between PD group and HC group

In thalamus, there was no significant difference in QSM parameters between HC group and PD group (p > 0.05). By contrast, QSM of substantia nigra, red nucleus, head of caudate nucleus and putamen of PD group was significantly greater than those of HC group (p < 0.05) (Table 15) (Figs. 8, 9, 10 and 11).

Table 15.

Comparison of ROI positions in QSM parameters between PD group and HC group

ROI position HC group
(Inline graphic)
PD group
(Inline graphic)
t/Z p
Substantia nigra 0.19 ± 0.05 0.12 ± 0.08 -2.200z 0.028
Red nucleus 0.18 ± 0.06 0.11 ± 0.08 -2.156z 0.031
Head of caudate nucleus 0.06 ± 0.02 0.02 ± 0.04 2.861 0.008
Putamen 0.06 ± 0.02 0.02 ± 0.03 2.762 0.010
Thalamus 0.00 ± 0.01 0.00 ± 0.03 0.381 0.706

Note: z-rank sum test

Fig. 8.

Fig. 8

Two groups of QSM box-plot of substantia nigra (p = 0.028)

Fig. 9.

Fig. 9

Two groups of QSM box-plot of red nucleus (p = 0.031)

Fig. 10.

Fig. 10

Two groups of QSM box-plot of head of caudate nucleus (p = 0.008)

Fig. 11.

Fig. 11

Two groups of QSM box-plot of putamen (p = 0.010)

Correlation analysis between QSM parameters and DKI parameters of ROI

There was no significant difference between QSM parameters and DKI parameters of ROI (p > 0.05) (Table 16).

Table 16.

Correlation analysis between QSM parameters and DKI parameters of ROI

ROI Substantia nigra Red nucleus Head of caudate nucleus Putamen Thalamus
MK

r = 0.090

P = 0.970

r = 0.050

P = 0.835

r=-0.226

P = 0.339

r=-0.212

P = 0.370

r = 0.126

P = 0.596

AK

r = 0.044

P = 0.855

r=-0.256

P = 0.277

r=-0.426

P = 0.061

r = 0.063

P = 0.791

r = 0.410

P = 0.073

RK

r=-0.239

P = 0.310

r = 0.158

P = 0.506

r=-0.237

P = 0.315

r=-0.213

P = 0.366

r=-0.077

P = 0.748

MD

r = 0.205

P = 0.387

r = 0.197

P = 0.405

r=-0.358

P = 0.121

r = 0.176

P = 0.458

r = 0.054

P = 0.821

FA

r=-0.285

P = 0.223

r=-0.153

P = 0.519

r=-0.385

P = 0.094

r=-0.174

P = 0.464

r=-0.167

P = 0.482

The ROC curve of DKI parameters at each ROI position

The maximum area under the ROC curve (AUC) of MD value was 0.823, the sensitivity was 70.0%, the specificity was 85.0%, and the diagnostic threshold was 0.414; the area under the ROC curve (AUC) of MK value in substantia nigra was 0.695, the sensitivity was 95.0%, the specificity was 50.0%, and the diagnostic threshold was 0.667. Both were statistically significant (p < 0.05) (Table 17) (Fig. 12).

Table 17.

ROC curve of DKI parameters at each ROI position

ROI position Parameters Sensitivity
(%)
Specificity
(%)
Yoden index Threshold AUC(95%CI) p
Substantia nigra MK 95.0 50.0 0.450 0.667 0.695(0.530,0.860) 0.035
AK 85.0 45.0 0.300 0.408 0.543(0.354,0.731) 0.646
RK 25.0 100.0 0.250 1.242 0.588(0.408,0.767) 0.344
MD 70.0 85.0 0.550 0.414 0.823(0.695,0.950) < 0.001
FA 90.0 30.0 0.200 0.167 0.518(0.333,0.702) 0.850
Red nucleus MK 95.0 25.0 0.200 0.424 0.513(0.327,0.698) 0.892
AK 5.0 95.0 0.000 1.090 0.370(0.195,0.545) 0.160
RK 25.0 95.0 0.200 1.225 0.583(0.403,0.762) 0.372
MD 90.0 55.0 0.450 0.397 0.663(0.488,0.837) 0.079
FA 50.0 60.0 0.100 0.183 0.480(0.297,0.663) 0.829
Head of caudate nucleus MK 5.0 100.0 0.050 1.218 0.343(0.169,0.516) 0.088
AK 100.0 10.0 0.100 0.112 0.400(0.218,0.582) 0.279
RK 5.0 100.0 0.050 1.367 0.330(0.161,0.499) 0.066
MD 95.0 35.0 0.300 0.367 0.648(0.475,0.820) 0.110
FA 25.0 80.0 0.050 0.112 0.398(0.218,0.577) 0.267
Putamen MK 95.0 15.0 0.100 0.337 0.380(0.199,0.561) 0.194
AK 10.0 100.0 0.100 0.994 0.405(0.225,0.585) 0.304
RK 45.0 70.0 0.150 0.645 0.475(0.291,0.659) 0.787
MD 95.0 35.0 0.300 0.355 0.638(0.463,0.812) 0.137
FA 100.0 20.0 0.200 0.059 0.583(0.403,0.762) 0.372
Thalamus MK 5.0 100.0 0.050 1.130 0.308(0.140,0.475) 0.037
AK 15.0 95.0 0.100 0.793 0.453(0.271,0.634) 0.607
RK 55.0 85.0 0.400 0.781 0.638(0.455,0.820) 0.137
MD 95.0 35.0 0.300 0.354 0.578(0.394,0.761) 0.402
FA 30.0 85.0 0.150 0.171 0.505(0.322,0.688) 0.957

Note: z-rank sum test

Fig. 12.

Fig. 12

The ROC curves of HC group and PD group of the parameters of substantia nigra position

Discussion

The main pathological changes of Parkinson’s disease are the degeneration of dopaminergic neurons in substantia nigra of midbrain and the presence of fiber eosinophilic inclusion bodies, namely Lewy bodies, which are mainly composed of alpha synuclein and ubiquitin [13]. Moreover, recent studies have also suggested that the disorder of iron metabolism in the brain may lead to neurodegenerative diseases such as Parkinson’s disease. The iron content in substantia nigra of patients with Parkinson’s disease increases significantly, and with the aggravation of the disease, the iron deposition increases [14]. Although the biological mechanism of abnormal iron metabolism in PD patients is not clear, it is certain that Parkinson’s disease is closely related to the imbalance of iron absorption, storage, transport and release, which may be the main factor leading to the loss of dopaminergic neurons and abnormal aggregation of α-synuclein.

There was no significant difference between the left and right sides of gray matter nuclei in 40 examinees. It showed that the degree of disease change and the dominance of left and right hands in patients with early Parkinson’s disease would not significantly affect the results of the study.

DKI is an extension of diffusion tensor imaging (DTI). It is a practical clinical technique for quantifying the diffusion of non normal water molecules and exploring the microstructure of biological tissues. The application direction of diffusion sensitive gradient field in DKI technology needs at least 15, and can be increased to 30 gradient field directions. The number of b values can be 3 or 5 [15]. In this study, by plotting and measuring the DKI parameters with different b values in the deep nuclei of normal human brain, five regions of interest were selected, namely, the substantia nigra, the red nucleus, the head of caudate nucleus, putamen and thalamus. After data analysis, it was found that there was no statistical difference between DKI3b scanning and DKI5b scanning. Therefore, it can be considered that the reduction of b value will not affect the image and data processing Therefore, DKI3b scan can be used instead of DKI5b scan in clinical practice, which can greatly shorten the scanning time and reduce the occurrence of events such as Parkinson’s disease due to the long scanning time. This adaption may provide the basis for the new clinical application of DKI technology in the future.

The main parameters of DKI include mean kurtosis (MK), axial kurtosis (AK), radial kurtosis (RK) and kurtosis anisotropy (KA). Scanning DKI sequence can also obtain DTI related parameters, including fractional anisotropy (FA), mean diffusion (MD), axial diffusion tensor (AD), and vertical diffusion tensor (RD). The DKI related parameters have higher sensitivity and specificity than DTI related parameters in evaluating the changes of microstructure of deep gray matter nuclei. Moreover, the parameter maps of DKI play an important clinical application value in the evaluation of disease evolution and process, therapeutic effect and prognosis follow-up.

DKI-MK is a parameter reflecting the complexity of brain microstructure. It takes the mean value of different b value directions in the same direction gradient direction. The size of MK depends on the structural complexity of the organization within the ROI range. In normal human brain tissue, the complexity of different parts is different, so MK is also different. The loss of dopaminergic neurons, oxidative stress, neuritis and other factors in PD patients can cause changes in the complexity of different parts. In this study, the increase of MK in substantia nigra in this study may indicate that early inflammation leads to a large number of glial cells and cytokine activation, which is more than the loss of dopaminergic neurons, which may lead to the increase of local complexity, which is consistent with the report that early neuroinflammation can effectively alleviate the degeneration of dopaminergic neurons [16]. However, it is different from the conclusion of some researchers, which may be related to the duration of disease and the severity of disease, which may lead to the increase of neuron damage. There are subthalamic nuclei (STN) in the thalamus. Due to the excessive loss of dopaminergic cells in the substantia nigra compacta of PD, the number of cells projecting to the striatum is reduced, which can lead to over activation of STN pathway and inhibit the cerebral cortex [17]. Excessive activation of STN may aggravate the damage of local tissues, and may lead to the decrease of MK, which is consistent with the conclusion of this paper.

Although MK does not depend on the spatial orientation of organizational structure, it ignores the directionality of diffusion movement [18]. AK and RK make up for the deficiency of MK, which can reflect the value of dispersion kurtosis along the fiber bundle direction and perpendicular to the fiber bundle direction respectively. It was found that the RK of the gray matter nuclei in both HC and PD groups was significantly greater than that of AK, indicating that the dispersion of water molecules with non normal distribution in the direction perpendicular to the fiber bundle was more significant. It is possible that the AK is smaller because the water molecules in the axial direction are relatively free; because the diffusion of water molecules is limited due to the blockage of myelin sheath, the RK is larger [19].

MD reflects the overall diffusion level and resistance of water molecules. In this study, the substantia nigra and the head of caudate nucleus in PD patients were increased, which indicated that the loss and degeneration of neurons and the loose structure between tissues might lead to the faster diffusion of water molecules. In this study, the MK value of substantia nigra in PD patients increased, and the MD value also increased. The possible reason is that although inflammatory factors and other results lead to the increase of local complexity, it should be lower than the degree of normal brain tissue relationship, so the increase of MD value can also exist. FA value reflects the non-uniformity of diffusion direction and velocity of water molecules in tissues. There is no statistical difference in DKI-FA value and DTI-FA value in all parts of this study, which is different from the conclusion that FA in substantia nigra of PD patients is significantly decreased [20]. It may be due to the early stage of PD patients with no obvious pathological changes, or it may be caused by the loss of dopaminergic neurons, iron deposition, scanning parameters and other confounding factors.

Based on the presence or absence of SWI and QSM in the diagnosis of substantia nigra swallow tail sign, QSM has higher diagnostic efficiency and higher negative predictive rate, which is similar to the research results of He Naying and Xu Hongmin [21]. QSM technology is based on the needs of clinical research, Yi Wang research group of Cornell University proposed on the basis of susceptibility weighted imaging (SWI). It is a technique for quantitative measurement of tissue magnetization characteristics, which can be applied to neurological diseases based on abnormal iron content [22]. Parkinson’s disease is associated with the loss of dopaminergic cells and excessive iron deposition in nuclei such as substantia nigra. This study showed that compared with HC group, the magnetic susceptibility of substantia nigra, red nucleus, caudate nucleus and putamen in PD group were increased, which indicated that there was excessive iron deposition in patients with early Parkinson’s disease.

There was no significant correlation between the magnetic susceptibility of gray matter nuclei and the corresponding DKI parameters, indicating that the abnormal iron deposition could not completely reflect the changes of the microstructure of gray matter nuclei in Parkinson’s disease patients. The abnormal iron deposition may be only one aspect of it, and other factors should be considered together, such as the loss of a large number of dopaminergic neurons, microglia and astrocytes cell activation.

The prevalence of Parkinson’s disease is increasing year by year, and the clinical diagnosis lacks objectivity. This study uses SWI, QSM, DTI and DKI techniques to provide multiple data for analysis. According to the changes in the structure of substantia nigra, putamen and dorsal thalamus of PD patients, it is possible to find the changes in the fine anatomical structure and pathological changes of the gray matter nuclei in the brain, which will help improve the accuracy of PD diagnosis and provide objective basis for clinical diagnosis. The study was a non-large sample experiment with relatively few samples, which has certain limitations. The image post-processing was tedious, and there may be some errors in manual measurement. It is expected that in the future research, on the basis of increasing the number of samples, the research methods of this paper will be used to verify whether the results obtained are consistent.

This current study is limited by the relatively small sample size. As a result, future investigations into the accuracy of MRI in diagnosing PD and objective imaging indicators for early clinical diagnosis and treatment would be recommended. Future studies might provide more definitive evidence by expanding the sample size and refining the grouping of PD cases. Future studies might also deep-dive into the effectiveness of medication by comparing PD cases taking medication with those not taking medication and evaluating the treatment efficacy of PD cases taking medication.

Acknowledgements

We thank all the study participants, research staff, and students who contributed to this study.

Authors’ contributions

Duo Zhang designed experiment,analyzed data and wrote the main manuscript text.Heng Meng wrote original draft,reviewed and edited draft.Qiyuan Sun prepared figures and data. All authors reviewed the manuscript.

Funding

The work was supported by Funding from the National Natural Foundation of the People’s Republic of China (Grant No. 81771803) and the science and technology development plan project of Jilin province (Grant No. 20200201323JC and 20210101204JC).

Data availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Declarations

Competing interests

All authors declare that they have no conflicts of interest to disclose.

Ethical approval and Consent to participate

This study was approved by the ethics committee of Affiliated Hospital of Beihua University, and all examiners signed informed consent.(Permit Number: 2020-16).

Consent for publication

Not applicable.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Li Z. Research progress on etiology and pathogenesis of Parkinson’s disease [J] J Int Neurol Neurosurg. 2014;41(04):345–8. [Google Scholar]
  • 2.Lv Z, Jiang H, Xu H et al. Increased iron levels correlative with the selective nigral dopaminergic neuron degeneration in Parkinson’s disease[J].Neural Transm 2011,118(3):361–9. [DOI] [PubMed]
  • 3.Peran P, Cherubini A, Assogna F, et al. Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature [J] Brain. 2010;133(11):3423–33. doi: 10.1093/brain/awq212. [DOI] [PubMed] [Google Scholar]
  • 4.Berg D, Gerlach M, Youdim MB, et al. Brain iron pathways and their relevance to Parkinson’s disease [J] Neurochem. 2001;79(2):225–36. doi: 10.1046/j.1471-4159.2001.00608.x. [DOI] [PubMed] [Google Scholar]
  • 5.Flannigan BD, Bradley WG, Jr, et al. Magnetic resonance imaging of the brainstem: normal structure and basic functional anatomy[J] Radiology. 1985;154(2):375–83. doi: 10.1148/radiology.154.2.3966125. [DOI] [PubMed] [Google Scholar]
  • 6.Schwarz ST, Rittman T, Gontu V, et al. T1-weighted MRI shows stage- dependent substantia nigra signal loss in Parkinson’s disease[J] Mov Disord. 2011;26(9):1633–8. doi: 10.1002/mds.23722. [DOI] [PubMed] [Google Scholar]
  • 7.Guo FL, Li T. Magnetic resonance imaging of substantia nigra in Parkinson’s disease [J] Stroke and Nervous Diseases. 2017;24(2):65–8. [Google Scholar]
  • 8.Blazejewska AI, Schwarz ST, Pitiot A, et al. Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7T MRI[J] Neurology. 2013;81(6):534–40. doi: 10.1212/WNL.0b013e31829e6fd2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Du G, Lewis MM, Styner M, et al. Combined R2* and diffusion tenor imaging changes in the substantia nigra in Parkinson’s disease [J] Mov Disord. 2011;26(9):1627–32. doi: 10.1002/mds.23643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Aquino D, Contarino V, Albanese A, et al. Substantia nigra in Parkinson’s disease: a multimodal MRI comparsion between early and advanced stages of the disease [J] Neurol Sci. 2014;25(5):753–8. doi: 10.1007/s10072-013-1595-2. [DOI] [PubMed] [Google Scholar]
  • 11.Schwarz ST, Abaei M, Gontu V, et al. Diffusion tensor imaging of nigral degeneration in Parkinson’s disease: a region-of-interedt and voxel- based study at 3T and systematic review with meta-analysis [J] Neuro- image Clin. 2013;3:481–8. doi: 10.1016/j.nicl.2013.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wang JJ, Lin WY, Lu CS et al. Parkinson disease: diagnostic utility of diffusion kurtosis imaging.Radiology,2011,26(1):210–7. [DOI] [PubMed]
  • 13.AKABAYASHI K, TANJI K, MORI F, et al. The Lewy body in parkin- son’s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates [J] Wakabayashi Koichitanji Kunikazumori Fumiakitak. 2007;27(5):494–506. doi: 10.1111/j.1440-1789.2007.00803.x. [DOI] [PubMed] [Google Scholar]
  • 14.Wang JW, Wang M, Wang DH, et al. The application value of susceptibility weighted imaging in measuring brain iron deposition in the clinical assessment of Parkinson’s disease [J] J Practical Radiol. 2016;32(4):493–6. [Google Scholar]
  • 15.Zeng DY. Application of diffusion kurtosis imaging (DKI) in central nervous system [J] J Clin Radiol. 2011;30(9):1400–2. [Google Scholar]
  • 16.DELEIDI M, GASSER T. The role of inflammation in sporadic and familial Parkinson’s disease [J] Cell Mol Life Sci. 2013;70(20):4259–73. doi: 10.1007/s00018-013-1352-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Zhang J, ZhangYT, He N, et al. Improved visibility of the subthalamic nucleus in PD patients using susceptibility-weighted imaging: a preliminary study [J] Chin J Magn Reson Imaging. 2011;02(5):353–7. [Google Scholar]
  • 18.Wang YL, Chu JP. Clinical progress of magnetic resonance diffusion kurtosis imaging [J] Diagn Imaging Interventional Radiol. 2015;24(4):340–5. [Google Scholar]
  • 19.STEVEN A J, ZHUO J, MELHEM E R. Diffusion kurtosis imaging:an emerging technique for evaluating the microstructural environment of the brain [J] Am J Roentgenol. 2014;202(1):26–33. doi: 10.2214/AJR.13.11365. [DOI] [PubMed] [Google Scholar]
  • 20.Shi F, Gao Y, Niu GM. Advanced research of MRI in Parkinson’s disease [J] J Practical Radiol. 2015;31(3):487–91. [Google Scholar]
  • 21.He NY, Xu HYM, Hang P, et al. Study of nigrosome-1 degeneration on imaging by quantitative susceptibility mapping in Parkinson’s disease patients [J] J Diagnostics Concepts Pract. 2017;16(2):147–51. [Google Scholar]
  • 22.Wang M, Li CF. Quantitative susceptibility MA Ping and its application in brain iron quantification [J] Chin Imaging J Integr Traditional Western Med. 2016;14(1):105–8. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.


Articles from Head & Face Medicine are provided here courtesy of BMC

RESOURCES